Nicolle Cavalcante Gaglionone

Nicolle Cavalcante Gaglionone

Auto-generated profile, based on publicly available information

Nicolle Cavalcante Gaglionone

Department of Pathology, Instituto D'OR de Pesquisa e Ensino, Rio de Janeiro, RJ, Brazil

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2018 in Journal of Cutaneous Pathology
Verified
Journal Article
Closed access
PDF file
RRRafaela Elvira Rozza‐De‐Menezes
Rafaela Elvira Rozza‐De‐Menezes
CBCarolina de Almeida Ito Brum
Carolina de Almeida Ito Brum
NGNicolle Cavalcante Gaglionone
Nicolle Cavalcante Gaglionone
LALilian Machado de Sousa Almeida
Lilian Machado de Sousa Almeida
RARaquel Machado Andrade‐Losso
Raquel Machado Andrade‐Losso
KCKarin Cunha
Karin Cunha

20 December 2017 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
RRRafaela E. Rozza-De-Menezes
Rafaela E. Rozza-De-Menezes
NGNicolle C. Gaglionone
Nicolle C. Gaglionone
RARaquel M. Andrade-Losso
Raquel M. Andrade-Losso
OSOrlando H. K. Siqueira
Orlando H. K. Siqueira
LALilian M. Almeida
Lilian M. Almeida
KCKarin Cunha
Karin Cunha
Multiple cutaneous neurofibromas are a hallmark of neurofibromatosis 1 (NF1). They begin to appear during puberty and increase in number and volume during pregnancy, suggesting a hormonal influence. Ghrelin is a hormone that acts via growth hormone secretagogue receptor (GHS-R), which is overexpressed in many neoplasms and is involved in tumorigenesis. We aimed to investigate GHS-R expression in NF1 cutaneous neurofibromas and its relationship with tumors volume, and patient’s age and gender. Sample comprised 108 cutaneous neurofibromas (55 large and 53 small tumors) from 55 NF1 individuals. GHS-R expression was investigated by immunohistochemistry in tissue micro and macroarrays and quantified using a digital computer-assisted method. All neurofibromas expressed GHS-R, with a percentage of positive cells ranging from 4.9% to 76.1%. Large neurofibromas expressed more GHS-R than the small ones. The percentage of GHS-R-positive cells and intensity of GHS-R expression were positively correlated with neurofibromas volume. GHS-R expression was more common in female gender. GHS-R is expressed in cutaneous neurofibromas. Larger neurofibromas have a higher percentage of positive cells and higher GHS-R intensity. Based on our results we speculate that ghrelin may have an action on the tumorigenesis of cutaneous neurofibromas. Future studies are required to understand the role of ghrelin in the pathogenesis of NF1-associated cutaneous neurofibroma.

1 January 2013 in Clinics
Verified
Journal Article
Open access
OSOrlando Hiroshi Kiono Siqueira
Orlando Hiroshi Kiono Siqueira
BFBenedito Herani Filho
Benedito Herani Filho
RPRafael Erthal de Paula
Rafael Erthal de Paula
FÁFábio Otero Áscoli
Fábio Otero Áscoli
ANAntonio Cláudio Lucas da Nóbrega
Antonio Cláudio Lucas da Nóbrega
JGJose M. Granjeiro
Jose M. Granjeiro
The aim of this study was to evaluate the effect of oral tamoxifen treatment on the number of myofibroblasts present during the healing process after experimental bile duct injury. The sample consisted of 16 pigs that were divided into two groups (the control and study groups). Incisions and suturing of the bile ducts were performed in the two groups. Tamoxifen (20 mg/day) was administered only to the study group. The animals were sacrificed after 30 days. Quantification of myofibroblasts in the biliary ducts was made through immunohistochemistry analysis using anti-alpha smooth muscle actin of the smooth muscle antibody. Immunohistochemical quantification was performed using a digital image system. In the animals treated with tamoxifen (20 mg/day), there was a significant reduction in immunostaining for alpha smooth muscle actin compared with the control group (0.1155 vs. 0.2021, p = 0.046). Tamoxifen reduced the expression of alpha smooth muscle actin in the healing tissue after bile duct injury, suggesting a decrease in myofibroblasts in the scarred area of the pig biliary tract. These data suggest that tamoxifen could be used in the prevention of biliary tract stenosis after bile duct surgeries.

9 January 2025 in Brazilian Journal of Oncology
Verified
Journal Article
Open access
PDF file
TOThamires Oliveira-Silva
Thamires Oliveira-Silva
CNCamila Naegele-Bazzanella
Camila Naegele-Bazzanella
MZMauro Zukin
Mauro Zukin
NCNicolle Cavalcante
Nicolle Cavalcante
ADAntônio Alexandre De-Oliveira-Siciliano
Antônio Alexandre De-Oliveira-Siciliano
CBClarissa Baldotto
Clarissa Baldotto
Crizotinib is a multi-tyrosine kinase inhibitor (mTKI) with efficacy in treating c-ROS oncogene 1-positive non-small cell lung cancer (NSCLC). The association between this TKI and the development of renal cysts is well established, although data on the formation of aseptic abscesses is scarce. We report a case of a patient with ROS1-positive NSCLC treated with crizotinib who developed multiple renal and extrarenal cysts and aseptic abscesses associated with a quick resolution of these lesions after the discontinuation of the TKI therapy. We aim to report a rare presentation of a drug-related adverse event with an unusual behavior.

30 October 2020 in Research Square
Verified
Preprint
Open access
PDF file
FSFernando Augusto Soares
Fernando Augusto Soares
COCristiano Claudino Olliveira
Cristiano Claudino Olliveira
MCMauro Canzian
Mauro Canzian
NGNicolle Cavalcante Gaglionone
Nicolle Cavalcante Gaglionone
CKClóvis Klock
Clóvis Klock
Background: COVID-19 pandemics affects the Health system all around the World. Brazil, since the first case in March, reported more than 4.0 million people infected. The pandemic's magnitude made that Hospitals prioritize the care of the secondary respiratory distress syndrome, and all elective diagnosis and treatment have been postponed. This study aimed to assess changes in patient's profiles submitted to lung or pleural biopsies comparing before and during COVID-19 pandemics.Methods: We retrospectively review the data of patients who underwent lung disease diagnostic approaches across April/May 2019 versus April/May 2020. We collect the data about the total cases, demographics, type of procedure, and disease diagnosis. Histological type, stage of the tumors, and molecular profile were also analyzed in cancer cases.Results: The number of total cases and lung biopsies dropped by more than 90% when the 2019/2020 samples were compared. Benign disease faced a more substantial reduction than cancer cases, with emphasis in granulomatous diseases. We had more advanced cases and more squamous cell carcinomas and small cell neuroendocrine carcinomas in the cancer scenario. Low-grade tumors, as carcinoids, suffered a significant reduction. Also, the molecular profile of the tumors drops in absolute numbers. Still, there was an increase of PD-L1 expression, probably because the sample comprises more squamous cell carcinomas and advanced cases.Conclusions: COVID-19 pandemics have a considerable negative impact on the management and diagnosis of lung diseases in Brazil. The consequences can be significant, and implementing a new policy to patients with lung diseases must be managed.